Explore Our Network

AdhexPharma is an independent contract development and manufacturing organization (CDMO) specializing in oral films and transdermal or topical patches for drug delivery. The company provides comprehensive end-to-end services from feasibility studies and formulation to analytical development, clinical batch production, and commercial manufacturing under cGMP. With expertise in complex dosage forms, handling potent APIs, and meeting global regulatory requirements, AdhexPharma integrates sustainable practices and operates advanced facilities in France and Germany, supporting both large pharmaceutical firms and biotech innovators worldwide.

Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Akthelia Pharmaceuticals is a pioneering biopharmaceutical company focused on developing therapeutics that enhance the body's innate defense mechanisms to combat debilitating diseases. The company targets mucosal barrier injury and epithelial integrity through a novel immunotherapeutic strategy. Its mission is to revolutionize treatment for diseases such as cancer, infection, and autoimmune disorders by leveraging the body's own microbial defense mechanisms.

Allvivo Vascular is a biomedical company dedicated to developing innovative antimicrobial technologies aimed at reducing infections related to medical devices and wounds. With a commitment to improving patient outcomes and healthcare economics, Allvivo collaborates with partners to deliver effective treatment options.

Altec is dedicated to advancing human potential by developing innovative human sensing technologies that enhance health science, operational security, and human performance. Founded in 1997 by Carlo De Luca, the company focuses on translating cutting-edge concepts into practical solutions that shape our understanding of human physiology. Altec's mission is to reimagine human potential through discovery, innovation, and collaboration, making significant strides in healthcare, security, and performance enhancement.

Altrazeal Life Sciences Inc. is a specialty medical technology company dedicated to developing and commercializing innovative drug delivery systems. Their mission is to improve patient outcomes by providing comprehensive solutions for patients, providers, and payers. The company is known for its patented Altrazeal® Transforming Powder Dressing, which optimizes the wound healing environment and supports tissue repair.

The American Burn Association (ABA) is a multidisciplinary organization dedicated to improving the lives of those affected by burn injury. With over 3,000 members worldwide, ABA focuses on promoting and supporting burn-related care, prevention, education, and research. The association brings together professionals from various disciplines to advance quality care, advocate for prevention, provide educational resources, and foster research in the field of burn injuries. ABA is also recognized for its leadership in advocacy, professional development, and the establishment of best practices and guidelines for burn care. The ABA regularly hosts conferences, develops clinical guidelines, and partners with organizations to raise awareness and improve outcomes for burn survivors.

Amsel Medical Corporation specializes in the development and commercialization of minimally invasive medical devices for trauma, vascular, and general surgical applications. Its core innovation centers on unique temporary and permanent vessel clamping technologies delivered via needle guidance. For trauma, the company is developing a field-deployable precision hemorrhage control solution for combat and civilian non-compressible junctional hemorrhage injuries . The solution can adjust the degree of vessel occlusion and distal perfusion, minimizing the potential consequences of prolonged limb ischemia and "reperfusion injury", and most importantly extends the "golden hour" for safe evacuation. Saving Limbs...Saving Lives.

Aphios is a green biotechnology company focused on developing enabling nanotechnology platforms and enhanced therapeutics for health maintenance, disease prevention, and treatment of various conditions including cancers, infectious diseases, and central nervous system (CNS) disorders. The company emphasizes environmentally-sustainable practices and aims to improve the quality of life through innovative therapies.

Arizona State University (ASU) is a comprehensive public research university known for its commitment to inclusivity, excellence, and societal impact. ASU is dedicated to advancing research-based solutions for global challenges, fostering strong leadership, and providing quality education accessible to all learners. The university is recognized for its innovative approach to education and its efforts in sustainability, research, and community service. ASU exemplifies a new prototype for the American public research university, focusing on excellence, broad access to quality education, and meaningful societal impact.

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat antibiotic-resistant and difficult-to-treat bacterial infections. With a focus on addressing the global antibiotic resistance crisis, Armata leverages its proprietary bacteriophage-based technology to develop high-impact, best-in-class phage therapeutics. The company operates from a 56,000 square foot facility in Los Angeles, California, equipped for phage product development from bench to clinic. Armata's team of microbiologists and scientists work on discovering natural phages and enhancing them through synthetic biology and engineering to create tailored drug products for clinical trials.

The Armed Forces Institute of Regenerative Medicine (AFIRM) , led by the Wake Forest Institute for Regenerative Medicine, is a collaborative effort involving over 30 academic institutions and industry partners. The consortium focuses on advancing regenerative medicine solutions for battlefield injuries, aiming to improve the lives of wounded service members, veterans, and the general public. With a $40 million, five-year award from the Defense Health Agency, AFIRM is dedicated to developing clinical therapies in areas such as craniofacial regeneration, extremity regeneration, genitourinary/lower abdomen, skin and wound healing, on-demand blood, and cellular therapies for trauma.

ARMR Sciences, Inc. is a biotechnology company dedicated to ending the fentanyl crisis and defending against synthetic drug threats through American innovation. The company is pioneering scalable, preventative immunotherapies to protect individuals before exposure to lethal synthetic drugs like fentanyl, moving beyond reactive treatments to address the root causes of overdose deaths. ARMR's technology is supported by foundational licenses from the Department of Defense and aligns with federal health and defense agencies. The multidisciplinary team brings significant experience from leading institutions and companies such as MindMed, iBio, Ridgeback Biotherapeutics, Scripps Research, Boston Children’s Hospital, Harvard Medical School, and more. United in their vision to save lives, ARMR is committed to providing lasting protection and solving the overdose crisis for millions in need.

Astek Diagnostics is a precision diagnostics company focused on revolutionizing the detection and treatment of bacterial infections. Their flagship product, the JIDDU system, offers rapid and accurate diagnostics for urinary tract infections (UTIs) and antibiotic sensitivity within one hour. This innovation aims to improve patient outcomes by reducing complications, healthcare costs, and antimicrobial resistance. Astek is committed to expanding its diagnostic capabilities to include multiple sample types, including urine, cerebrospinal fluid (CSF), effluent, and blood, with a market launch planned for 2025.

ATD Emolda has been delivering innovative solutions for 40 years, specializing in the conversion and manufacturing of components and assemblies for industrial, medical, and pharmaceutical applications. The company has become a thought leader in advanced wound care materials, focusing on developing high-performance polyurethane foams and silicone adhesives.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

AvantGuard has developed a novel broad-spectrum, bio-compatible antiseptic that is proven in in vitro, ex vivo, and in vivo testing to be safe and more effective than topical antibiotics, while also effective as a liquid sterilant or disinfectant. Our compound, Avantamine, can be packaged as a heat-tolerant, long-shelf-life powder in a metal foil packet that dissolves rapidly in potable water to make either a solution or hydrogel. At a high concentration, Avantamine's non-hazardous, non-corrosive solution will sterilize medical equipment in 10 minutes and is safe enough for instruments to be removed and used without rinsing. Diluted by half, Avant24 at 0.6% concentration is (1) an antiseptic for washing wounds or treating cutaneous bacterial and fungal infections, (2) a high-level disinfectant for a variety of medical devices without corroding metals or degrading plastics, and (3) a disinfectant for surfaces in the surgical suite. At 6X further dilution, Avant24 can treat trench mouth. At another 3X dilution, Avant24 can be added to water to make it drinkable. There are an enormous number of potential uses and the only difference between them is the amount of diluent, in this case water, used to prepare the solution. Our military focus areas are (1) low resource sterilization of medial devices, (2) fungal treatment for burn wounds, and (3) a prophylactic for infection control in a self-administered Role 1 environment with the powder applied directly to a wound. Our commercial focus area is Candida auris decolonization which is not currently possible with any other antiseptic. We have definitive animal testing to show efficacy and superiority to chlorhexidine and are moving toward the clinic.

Base Pair Biotechnologies specializes in custom aptamer discovery and development for research, diagnostics, therapeutics, and industrial applications. The company leverages proprietary multiplex selection, advanced bioinformatics, and chemical modification techniques to develop high-affinity and selective nucleic acid aptamers. Base Pair enables affinity reagent development, biosensor design, and molecular detection for a broad range of targets and partners across academia and industry.

Battelle is an independent nonprofit organization dedicated to advancing science and technology to address the world's most pressing challenges. With over 90 years of experience, Battelle transforms knowledge into profound innovation, reinvesting its proceeds into scientific advancement and STEM education. The organization operates across various markets, including health, national security, environment, infrastructure, and industry, providing solutions through limitless innovation and expertise in scientific and engineering disciplines.